Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 10)
Protagonist Therapeutics Reports Resolution Of Contract Dispute With Zealand Pharma; Protagonist To Make $1.5M Payment To Zealand
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or "the Company") today announced it has resolved its Collaboration Agreement dispute with Zealand Pharma by reducing future development and
Zealand Pharma Announces U.S. Commercial Availability of ZEGALOGUE Injection
Zealand Pharma A/S (NASDAQ:ZEAL) (CVR-no. 20045078) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that
Earnings Scheduled For May 12, 2021
Companies Reporting Before The Bell
• PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter.